GlassScriptPhysician profile
Sainath Gaddam
NPI 1912142985
$3,438.85
in general payments reported to CMS, 2019-2025
26 companies · $422 in 2025
The $422 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $62.04 · 2021: $380 · 2022: $858 · 2023: $1,205 · 2024: $302 · 2025: $422.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,929.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,928.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $917.19 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $273.14 | 2019-2025 | Avvigo Guidance System, Watchman Access System, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $239.67 | 2019-2022 | |
| Abiomed | $233.40 | 2021-2022 | |
| Terumo Medical Corporation | $186.50 | 2021 | |
| Novo Nordisk INC | $166.68 | 2024-2025 | Ozempic |
| Biotronik INC. | $156.89 | 2022 | |
| Cleerly, INC. | $155.60 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Medtronic, INC. | $152.62 | 2022-2023 | Turbohawk |
| Heartflow, INC. | $147.41 | 2023 | Ffrct |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $118.29 | 2019-2025 | Lifevest |
| Biosense Webster, INC. | $118.22 | 2022 | |
| Impulse Dynamics (USA) INC. | $106.19 | 2022-2025 | Optimizer |
| Pfizer INC. | $104.24 | 2022-2023 | |
| Cardiovascular Systems INC. | $71.33 | 2023 | Diamondback Peripheral |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $69.60 | 2024 | (Br5) Peripheral Ivus, (Ck4) Mcot |
| Teva Pharmaceuticals USA, INC. | $34.10 | 2023 | Austedo |
| Janssen Pharmaceuticals, INC | $33.39 | 2019-2022 | |
| Siemens Medical Solutions USA, INC. | $32.44 | 2024 | Biograph Horizon-3r |
| Amgen INC. | $27.54 | 2021-2025 | Repatha |
| Medtronic Vascular, INC. | $19.59 | 2019 | |
| Acist Medical Systems, INC. | $16.81 | 2019 | |
| Osprey Medical INC | $16.00 | 2019 | |
| Esperion Therapeutics, INC. | $14.98 | 2021 | |
| Theratechnologies INC. | $14.37 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sainath Gaddam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.